2026

SETDB1 in Breast Cancer Progression: Oncogenic Mechanisms and Subtype-Specific Prognostic Implications

First Author

My second published paper — a study of SETDB1, a histone methyltransferase whose oncogenic effects span tumor-suppressor silencing, cancer stem cell maintenance, and immune evasion, and how its prognostic role shifts across breast cancer subtypes in TCGA, METABRIC, and KM Plotter datasets.

Curiex Spring and Summer July Issue, Part 3, Page 213 ↗

SETDB1 in Breast Cancer Progression: Oncogenic Mechanisms and Subtype-Specific Prognostic Implications, page 1

1 / 23